Clinical Trials Logo

Clinical Trial Summary

Deprescribing is defined as "the process of withdrawal of an inappropriate medication, supervised by a health care professional with the goal of managing the polypharmacy and improving outcomes". Inappropriate use of proton pump inhibitors (PPI) is associated with severe adverse drug reactions and a major economic impact. Deprescribing should be considered when inappropriate prescription of PPI is identified. DeprescrIPP DAM is a pragmatic trial, population-based, designed in clusters. It wil assess the efficacy of a multi-faceted intervention (an educational outreach visit to general practitioners associated with the sending of patient education material to their patients) to deprescribe PPI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04513834
Study type Interventional
Source Nantes University Hospital
Contact
Status Completed
Phase N/A
Start date September 19, 2022
Completion date December 19, 2023

See also
  Status Clinical Trial Phase
Completed NCT04255823 - Efficacy of a Multi-faceted Intervention to Deprescribe Proton Pump Inhibitors (PPI) in Primary Care: a Population-based, Pragmatic, Cluster-randomized Controlled Trial. N/A
Completed NCT03719170 - Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program N/A
Completed NCT02558049 - Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid N/A
Completed NCT01130935 - Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium N/A
Recruiting NCT05582174 - PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers Phase 4
Recruiting NCT00709046 - High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment N/A
Not yet recruiting NCT06129474 - Deprescribing Inappropriate Proton Pump Inhibitors N/A
Completed NCT01231867 - Cohort Study of Clopidogrel and Proton Pump Inhibitors N/A